14-03-2025 15:37 via medpagetoday.com

Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly Dosing

(MedPage Today) -- SAN FRANCISCO--A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of plasma concentrations compared with twice-yearly subcutaneous lenacapavir for HIV pre...
Read more ยป

Medical news



Probiotics Cut Fever Duration in Kids With Upper Respiratory Infections
Therapy Dogs Cut Anxiety for Children in the ED
Studies Hint at Potential Negative Effects of GLP-1 Drugs in Orthopedic Patients
Proteinuria Linked to Sudden Cardiac Arrest in Young Adults
Paradoxical PSA Association With Mortality After Radical Prostatectomy
Dr. Oz Gets Generally Good Reception in Confirmation Hearing for CMS Administrator
Measles Cases Reach 294 in Texas and New Mexico: Here's What to Know
Clonidine Reduced Blood Loss, Transfusions in Pelvic/Acetabular Fracture Surgery
RFK Jr. Falsely Claims Measles Vax Causes Deaths 'Every Year'
Approved Sickle Cell Drug Fails to Beat Placebo in Trial
High Price of GLP-1 Agents Tip Cost-Benefit Scale Unfavorably
New-Onset Seasonal Allergies in Adults
The Risks of Universal Water Fluoridation and 'No Known Harm'
Scrubs, Sweat, and Solidarity: Making Friends in Residency
Desktop versie